Performance evaluation of a CD34 expression assay by digital PCR in bone marrow harvest from healthy donors
Transfusion · 2026-11 · 66 (11) · 2293-2301
DOI: 10.1111/trf.70267 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Transfusion, online erschienen am 01.06.2026. Verfasst von Miguel Waterhouse und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Freiburg, Germany. Hauptthemen laut MEDLINE: Antigens, CD34, Tissue Donors, Bone Marrow Cells, Polymerase Chain Reaction. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The aim of this study was to investigate a CD34 expression assay as an additional tool for the total nucleated cell (TNC) count assessment in bone marrow harvest (BMH) obtained from healthy donors. Study Design and Methods Samples obtained from bone marrow donors ( n = 71) were analyzed for CD34 expression using a digital PCR assay. The assay was extensively validated and the obtained data was correlated with standard BMH assessment methods such as TNC counts performed using a hematology analyzer and CD34 cell count measured with flow cytometry.
Results
The digital PCR CD34 assay showed a strong correlation with the TNC count (Spearman's r s 0.87, 95% CI: 0.78–0.92, p < .001) and also with the CD34 cell count assessed by flow cytometry (Spearman's r s 0.91, 95% CI: 0.84–0.94, p < .001). To analyze the diagnostic performance of the assay, the true‐positive rate (sensitivity) and the false‐positive rate (1 − specificity) were plotted in a receiver‐operating characteristic (ROC) space. The ROC curve showed an area under the curve (AUC) of 0.96 (95% confidence interval 0.91–1.01, p < .005). The CD34 NCN per kilogram of recipient body weight threshold of 0.54 resulted in a sensitivity of 0.91, a specificity of 0.96, a positive and negative predictive value of 0.97 and 0.91, respectively.
Conclusions
The CD34 expression assay here described can be used as an additional tool for TNC count estimation after BMH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Oncology and Stem Cell Transplantation, Freiburg University Medical Center, Freiburg, Germany.
ORCID-Profile: Robert Zeiser, Ralph Wäsch
Zitieren
APA
Waterhouse, M., Kaufmann, A., David, M., Enger, S., Sieder, M., Siegmund, D., Pantic, M., Rawluk, J., Zeiser, R., Wehr, C., Wäsch, R., Duyster, J., Finke, J., & Kiote-Schmidt, C. (2026). Performance evaluation of a CD34 expression assay by digital PCR in bone marrow harvest from healthy donors. Transfusion, 66(11), 2293-2301. https://doi.org/10.1111/trf.70267
Vancouver
Waterhouse M, Kaufmann A, David M, Enger S, Sieder M, Siegmund D, et al. Performance evaluation of a CD34 expression assay by digital PCR in bone marrow harvest from healthy donors. Transfusion. 2026;66(11):2293-2301. doi:10.1111/trf.70267
BibTeX
@article{Waterhouse2026,
author = {Waterhouse, Miguel and Kaufmann, Anja and David, Martina and Enger, Sabine and Sieder, Melanie and Siegmund, Darina and Pantic, Milena and Rawluk, Justyna and Zeiser, Robert and Wehr, Claudia and Wäsch, Ralph and Duyster, Justus and Finke, Jürgen and Kiote-Schmidt, Chrissoula},
title = {Performance evaluation of a CD34 expression assay by digital PCR in bone marrow harvest from healthy donors},
journal = {Transfusion},
year = {2026},
volume = {66},
number = {11},
pages = {2293--2301},
doi = {10.1111/trf.70267}
}
EUVIMED